Improve Safety With PDE5 Inhibitors

June 2022

Questions are coming up about the safety of PDE5 inhibitors (sildenafil, tadalafil, etc)...due to more data about eye problems.

Labels already warn of rare optic neuropathy...which can cause loss of vision that may be permanent.

Now a study suggests that this and other serious eye conditions occur in more patients than previously estimated.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Work as a Team to Navigate Staffing Shortages
Bites & Stings Sort Through the Swarm of Insect Repellents
Insomnia Think of Quviviq as Similar to Belsomra or Dayvigo for Insomnia
Travel Medicine Listen for Questions About Preventing Blood Clots During Travel
Practice Optimize Care for Patients With Disabilities
Specialty Meds Understand Unique Considerations With Specialty Meds
Cancer Help Overcome Barriers With Opioid Rxs for Cancer Pain
Med Safety Improve Safety With PDE5 Inhibitors
IBS Watch for Ibsrela, a New Rx for Irritable Bowel Syndrome